The Utility of Maternal Adiponectin and Triglyceride-Glycemic Index for Gestational Diabetes Mellitus Screening: A Cross-Sectional Study

Background: Gestational diabetes mellitus (GDM) is one of the most prominent diseases seen in pregnancy that adversely affects materno-fetal welfare. It is usually screened by an oral glucose tolerance test (GTT), which has some limitations. Adiponectin and triglyceride-glycemic (...

Full description

Saved in:
Bibliographic Details
Main Authors: H.A.G. Al-Rawi, Wassan Nori, Dina Akeel Salman, Abdulkareem H. Issa, Wisam Akram
Format: Article
Language:English
Published: IMR Press 2024-12-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/51/12/10.31083/j.ceog5112262
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850237180140584960
author H.A.G. Al-Rawi
Wassan Nori
Dina Akeel Salman
Abdulkareem H. Issa
Wisam Akram
author_facet H.A.G. Al-Rawi
Wassan Nori
Dina Akeel Salman
Abdulkareem H. Issa
Wisam Akram
author_sort H.A.G. Al-Rawi
collection DOAJ
description Background: Gestational diabetes mellitus (GDM) is one of the most prominent diseases seen in pregnancy that adversely affects materno-fetal welfare. It is usually screened by an oral glucose tolerance test (GTT), which has some limitations. Adiponectin and triglyceride-glycemic (TyG) index were two biomarkers examined in the GDM context with inconclusive effectiveness. This study aimed to examine both markers' performance in screening for GDM among Iraqi women. Methods: An observational cross-sectional study recruited gestational age and body mass index (BMI) matched pregnant at 26–28 weeks into two groups: healthy controls (n = 44/88) and GDM cases (n = 44/88). Participants' demographics, biochemical [FBS (fasting blood sugar), 2hr_GTT (2-hour glucose tolerance test), HDL (high-density lipoprotein), LDL (low-density lipoprotein), total cholesterol, TG (triglyceride), and TyG index], and hormonal (adiponectin) were recorded. Results: Serum adiponectin was significantly higher among healthy pregnant (8.44 ± 1.12 ng/mL vs. 5.28 ± 0.89 ng/mL); p < 0.0001. In contrast, the TyG index was significantly higher among GDM cases (4.02 ± 0.04 vs. 3.96 ± 0.02; p < 0.0001). Adiponectin showed strong inverse links with FBS, 2hr_GTT with r = (–0.76, –0.80); p < 0.0001, respectively. TyG index was moderately, inversely, and significantly linked to serum adiponectin as r = –0.58; p < 0.0001. Adiponectin and TyG index reliably predicted GDM with a high area under the curve of 0.83 vs. 0.88; p < 0.001, respectively. Conclusions: Both biomarkers correlated well to GDM parameters and showed high sensitivity and specificity in screening for GDM. Their efficiency, easy integrations in practice, and promising therapeutic application suggested by researchers warrant further studies.
format Article
id doaj-art-2d92126073204d4aa7dfc3df2219986c
institution OA Journals
issn 0390-6663
language English
publishDate 2024-12-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-2d92126073204d4aa7dfc3df2219986c2025-08-20T02:01:47ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632024-12-01511226210.31083/j.ceog5112262S0390-6663(24)02506-5The Utility of Maternal Adiponectin and Triglyceride-Glycemic Index for Gestational Diabetes Mellitus Screening: A Cross-Sectional StudyH.A.G. Al-Rawi0Wassan Nori1Dina Akeel Salman2Abdulkareem H. Issa3Wisam Akram4College of Medicine/Department of Obstetrics and Gynecology, Mustansiriyah University, 10052 Baghdad, IraqCollege of Medicine/Department of Obstetrics and Gynecology, Mustansiriyah University, 10052 Baghdad, IraqCollege of Medicine/Department of Obstetrics and Gynecology, Mustansiriyah University, 10052 Baghdad, IraqCollege of Medicine/Chemistry and Biochemistry Department, Mustansiriyah University, 10052 Baghdad, IraqCollege of Medicine/Department of Obstetrics and Gynecology, Mustansiriyah University, 10052 Baghdad, IraqBackground: Gestational diabetes mellitus (GDM) is one of the most prominent diseases seen in pregnancy that adversely affects materno-fetal welfare. It is usually screened by an oral glucose tolerance test (GTT), which has some limitations. Adiponectin and triglyceride-glycemic (TyG) index were two biomarkers examined in the GDM context with inconclusive effectiveness. This study aimed to examine both markers' performance in screening for GDM among Iraqi women. Methods: An observational cross-sectional study recruited gestational age and body mass index (BMI) matched pregnant at 26–28 weeks into two groups: healthy controls (n = 44/88) and GDM cases (n = 44/88). Participants' demographics, biochemical [FBS (fasting blood sugar), 2hr_GTT (2-hour glucose tolerance test), HDL (high-density lipoprotein), LDL (low-density lipoprotein), total cholesterol, TG (triglyceride), and TyG index], and hormonal (adiponectin) were recorded. Results: Serum adiponectin was significantly higher among healthy pregnant (8.44 ± 1.12 ng/mL vs. 5.28 ± 0.89 ng/mL); p < 0.0001. In contrast, the TyG index was significantly higher among GDM cases (4.02 ± 0.04 vs. 3.96 ± 0.02; p < 0.0001). Adiponectin showed strong inverse links with FBS, 2hr_GTT with r = (–0.76, –0.80); p < 0.0001, respectively. TyG index was moderately, inversely, and significantly linked to serum adiponectin as r = –0.58; p < 0.0001. Adiponectin and TyG index reliably predicted GDM with a high area under the curve of 0.83 vs. 0.88; p < 0.001, respectively. Conclusions: Both biomarkers correlated well to GDM parameters and showed high sensitivity and specificity in screening for GDM. Their efficiency, easy integrations in practice, and promising therapeutic application suggested by researchers warrant further studies.https://www.imrpress.com/journal/CEOG/51/12/10.31083/j.ceog5112262adiponectingestational diabetes mellitusscreeningtriglyceride-glycemic index
spellingShingle H.A.G. Al-Rawi
Wassan Nori
Dina Akeel Salman
Abdulkareem H. Issa
Wisam Akram
The Utility of Maternal Adiponectin and Triglyceride-Glycemic Index for Gestational Diabetes Mellitus Screening: A Cross-Sectional Study
Clinical and Experimental Obstetrics & Gynecology
adiponectin
gestational diabetes mellitus
screening
triglyceride-glycemic index
title The Utility of Maternal Adiponectin and Triglyceride-Glycemic Index for Gestational Diabetes Mellitus Screening: A Cross-Sectional Study
title_full The Utility of Maternal Adiponectin and Triglyceride-Glycemic Index for Gestational Diabetes Mellitus Screening: A Cross-Sectional Study
title_fullStr The Utility of Maternal Adiponectin and Triglyceride-Glycemic Index for Gestational Diabetes Mellitus Screening: A Cross-Sectional Study
title_full_unstemmed The Utility of Maternal Adiponectin and Triglyceride-Glycemic Index for Gestational Diabetes Mellitus Screening: A Cross-Sectional Study
title_short The Utility of Maternal Adiponectin and Triglyceride-Glycemic Index for Gestational Diabetes Mellitus Screening: A Cross-Sectional Study
title_sort utility of maternal adiponectin and triglyceride glycemic index for gestational diabetes mellitus screening a cross sectional study
topic adiponectin
gestational diabetes mellitus
screening
triglyceride-glycemic index
url https://www.imrpress.com/journal/CEOG/51/12/10.31083/j.ceog5112262
work_keys_str_mv AT hagalrawi theutilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT wassannori theutilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT dinaakeelsalman theutilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT abdulkareemhissa theutilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT wisamakram theutilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT hagalrawi utilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT wassannori utilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT dinaakeelsalman utilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT abdulkareemhissa utilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy
AT wisamakram utilityofmaternaladiponectinandtriglycerideglycemicindexforgestationaldiabetesmellitusscreeningacrosssectionalstudy